• Home
  • >
  • Journal of Pharmaceutical Sciences & Drug Technology

The Journal of Pharmaceutical Sciences & Drug Technology (JPSDT) is a peer-reviewed, open-access journal dedicated to the dissemination of innovative research and advancements in the fields of pharmaceutical sciences and drug technology. JPSDT serves as a platform for scientists, researchers, and professionals to share knowledge that contributes to the development and optimization of drug discovery, formulation, delivery, and therapeutic strategies.​

The journal encompasses a broad spectrum of topics, including but not limited to drug design, pharmacokinetics, pharmacodynamics, nanotechnology-based drug delivery systems, biotechnology, pharmacogenomics, and regulatory affairs. By fostering interdisciplinary collaboration, JPSDT aims to accelerate the translation of scientific discoveries into clinical applications, ultimately enhancing patient care and treatment outcomes.​

Committed to maintaining high ethical standards and rigorous peer-review processes, JPSDT ensures the publication of high-quality, impactful research that addresses current challenges and future directions in pharmaceutical sciences and drug technology.​

Journal Highlights:

  • Drug Design
  • Pharmaceutical Formulation
  • Nanotechnology in Drug Delivery
  • Pharmacokinetics and Pharmacodynamics
  • Biopharmaceuticals
  • Pharmacogenomics
  • Regulatory Affairs in Pharmaceuticals
  • Clinical Pharmacy
  • Medicinal Chemistry
  • Pharmaceutical Biotechnology
  • Drug Discovery
  • Drug Formulation
  • Nanotechnology in Drug Delivery
  • Controlled Release Systems
  • Pharmacokinetics
  • Pharmacodynamics
  • Bioavailability
  • Biopharmaceutics
  • Clinical Pharmacology
  • Medicinal Chemistry
  • Pharmaceutical Analysis
  • Pharmacogenomics
  • Personalized Medicine
  • Drug Targeting
  • Solid Dosage Forms
  • Injectable Drug Delivery
  • Liposomal Drug Delivery
  • Transdermal Drug Systems
  • Oral Drug Delivery
  • Inhalation Therapy
  • Drug Stability Studies
  • Quality by Design (QbD)
  • Regulatory Affairs
  • Good Manufacturing Practice (GMP)
  • Preclinical Drug Development
  • Clinical Trials
  • Toxicology Studies

Editor-in-Chief

Dr. Cristian-Catalin Gavat

Professor, Biomedical Sciences Department
Grigore T Popa University of Medicine and Pharmacy, Romania

Editors

Chung-Yi Chen
Marlies Gijs

Institute of Advanced Pharmaceutical Innovation, Northbridge University, UK

B. Bharathiraja

Professor, Department of Chemical Engineering Vel Tech High Tech Engineering College Anna University

Emmanuel Richaud

Professor, Oxidative ageing of polymeric materials and Hydrolytic Ageing of networks

Scroll to Top